Abstract
Objective To observe the clinical efficacy and safety of dibutyryl cyclophosphamide calcium injection combined with atorvastatin calcium tablets in the treatment of chronic heart failure.Methods A total of 132 patients with chronic heart failure were randomly divided into control group(n=67 cases)and treatment group(n=65 cases).The control group was treated with atorvastatin calcium tablets,the initial dose was 10 mg·d-1,and the dosage was adjusted according to the blood lipid control,and the maximum dose was not more than 80 mg·d-1.On the basis of control group,the treatment group was given dibutyryl cyclophosphamide calcium 40 mg,qd,intravenous drip.Two groups were treated for 2 weeks.The clinical efficacy,blood growth differentiation factor-15(GDF-15),vascularization-2(VS-2),left ventricular ejection fraction(LVEF)and cardiac output(CO),and adverse drug reactions were compared between two groups.Results After treatment the total effective rates of treatment and control groups were 90.77%(59 cases/65 cases)and 59.70%(40 cases/67 cases)with significant difference(P0.05).Conclusion Dibutyryl cyclophosphamide calcium injection combined with atorvastatin calcium tablets has a definitive clinical efficacy in the treatment of chronic heart failure,without increasing the incidence of adverse drug reactions.
| Translated title of the contribution | Clinical trial of dibutyryl cyclophosphamide calcium injection combined with atorvastatin calcium tablets in the treatment of patients with chronic heart failure |
|---|---|
| Original language | Chinese |
| Pages (from-to) | 3414-3417 |
| Number of pages | 4 |
| Journal | The Chinese Journal of Clinical Pharmacology |
| Volume | 36 |
| Issue number | 21 |
| DOIs | |
| State | Published - 1 Nov 2020 |
Funding
湖北省自然科学基金资助项目(2017CFC874);武汉市卫计委科研基金资助项目(WX18D06)。
Indexed by
- CSCD
Fingerprint
Dive into the research topics of 'Clinical trial of dibutyryl cyclophosphamide calcium injection combined with atorvastatin calcium tablets in the treatment of patients with chronic heart failure'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver